title: Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury.
abstract: Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) have a number of in vitro functions that could be important in vivo in acute liver injury and repair. Therefore, we investigated these two cytokines in acute liver damage. Northern blots of RNA isolated from rats sacrificed at various time intervals after a single oral dose of CCl4 revealed that TNF-alpha mRNA levels were elevated within 6 hr of CCl4 administration and returned to control values by 24-32 hr. In contrast, TGF-beta 1 mRNA levels started to rise significantly at 24 hr, peaked at 48 hr, and approached baseline levels by 72 hr. Identical changes in TNF-alpha and TGF-beta 1 mRNA levels were also seen with D-galactosamine-induced hepatotoxicity. Immunohistochemical analysis using a TGF-beta 1 antibody demonstrated increased hepatic staining in CCl4-treated rats, at times corresponding to the increases in TGF-beta 1 gene expression. Therefore, there is a differential expression of these cytokines in acute CCl4 and galactosamine hepatotoxicity with an early rise in TNF-alpha, suggesting that this cytokine may affect inflammation and cell toxicity, while TGF-beta 1 peaks later, when it may regulate hepatocyte proliferation and extracellular matrix repair.
authors.affiliation: Albert Einstein College of Medicine, Liver Research Center, New York, New York 10461.
authors.forename: M J
authors.initials: MJ
authors.lastname: Czaja
authors.forename: K C
authors.initials: KC
authors.lastname: Flanders
authors.forename: L
authors.initials: L
authors.lastname: Biempica
authors.forename: C
authors.initials: C
authors.lastname: Klein
authors.forename: M A
authors.initials: MA
authors.lastname: Zern
authors.forename: F R
authors.initials: FR
authors.lastname: Weiner
mesh_terms: D000208:Acute Disease; D000818:Animals; D015152:Blotting, Northern; D002251:Carbon Tetrachloride; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D004195:Disease Models, Animal; D005688:Galactosamine; D007124:Immunoenzyme Techniques; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D014158:Transcription, Genetic / Q000187:drug effects; D015291:Transforming Growth Factors / Q000096:biosynthesis* / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D005688:Galactosamine; D015291:Transforming Growth Factors; D002251:Carbon Tetrachloride